prof. dr. E. (Edwin) Bremer

Adjunct Hoogleraar

Faculteit Medische Wetenschappen/UMCG

Telefoon:

050 361 4324

050 36 32796 (fax)

E-mail:

e.bremer umcg.nl

ORCID Research Portal

Publicaties

Antibody desolvation with sodium chloride and acetonitrile generates bioactive protein nanoparticles

Nelemans, L. C., Melo, V. A., Buzgo, M., Bremer, E. & Simaite, A., 14-mrt.-2024, In: PLoS ONE. 19, 3, 17 blz., e0300416.

Onderzoeksoutput › › peer review

Design of Vaterite Nanoparticles for Controlled Delivery of Active Immunotherapeutic Proteins

Nelemans, L. C., Choukrani, G., Ustyanovska-Avtenyuk, N., Wiersma, V. R., Dähne, L. & Bremer, E., jul.-2024, In: Particle and Particle Systems Characterization. 41, 7, 11 blz., 2300153.

Onderzoeksoutput › › peer review

Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies

Bilemjian, V., Lin, Y., Wan, W., Egri, G., Huls, G., Heinze, T., Bremer, E., Gericke, M. & Dähne, L., 1-mrt.-2024, In: ChemBioChem. 25, 5, 12 blz., e202300828.

Onderzoeksoutput › › peer review

Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage

Visser, N., Herreman, L. C. M., Vandooren, J., Pereira, R. V. S., Opdenakker, G., Spelbrink, R. E. J., Wilbrink, M. H., Bremer, E., Gosens, R., Nawijn, M. C., van der Ende-Metselaar, H. H., Smit, J. M., Laus, M. C. & Laman, J. D., apr.-2024, In: Journal of Molecular Medicine. 102, blz. 521–536 16 blz.

Onderzoeksoutput › › peer review

Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases

Wang, L., Lin, Y., Yao, Z., Babu, N., Lin, W., Chen, C., Du, L., Cai, S., Pan, Y., Xiong, X., Ye, Q., Ren, H., Zhang, D., Chen, Y., Yeung, S.-C. J., Bremer, E. & Zhang, H., sep.-2024, In: Drug Resistance Updates. 76, 101118.

Onderzoeksoutput › › peer review

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

Lin, Y., Choukrani, G., Dubbel, L., Rockstein, L., Freile, J. A., Qi, Y., Wiersma, V., Zhang, H., Koch, K.-W., Ammatuna, E., Schuringa, J. J., van Meerten, T., Huls, G. & Bremer, E., 29-mrt.-2024, In: Experimental Hematology & Oncology. 13, 18 blz., 35.

Onderzoeksoutput › › peer review

A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics

Álvarez Freile, J., Qi, Y., Jacob, L., Lobo, M. F., Lourens, H. J., Huls, G. & Bremer, E., 25-jul.-2023, In: Frontiers in Immunology. 14, 15 blz., 1233113.

Onderzoeksoutput › › peer review

Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit

Johanna, I., Daudeij, A., Devina, F., Nijenhuis, C., Nuijen, B., Romberg, B., de Haar, C., Haanen, J., Dolstra, H., Bremer, E., Sebestyen, Z., Straetemans, T., Jedema, I. & Kuball, J., dec.-2023, In: Immuno-Oncology Technology. 20, 9 blz., 100411.

Onderzoeksoutput › peer review

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells

Melo, V., Nelemans, L. C., Vlaming, M., Lourens, H. J., Wiersma, V. R., Bilemjian, V., Huls, G., de Bruyn, M. & Bremer, E., 20-jul.-2023, In: Frontiers in Immunology. 14, 16 blz., 1191866.

Onderzoeksoutput › › peer review

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance

Choukrani, G., Visser, N., Ustyanovska Avtenyuk, N., Olthuis, M., Marsman, G., Ammatuna, E., Lourens, H. J., Niki, T., Huls, G., Bremer, E. & Wiersma, V. R., 6-jul.-2023, In: Cell Death and Discovery. 9, 12 blz., 228.

Onderzoeksoutput › › peer review

Lees meer

Alle (99) publicaties

Pers / media: Onderzoek ›

Lees meer

Alle (10) pers/media

Bekijk volledig onderzoeksprofiel